Kidney Cancer Treatment Price Comparison in Surat vs Turkey

Name: Post Title
Creator: Liv Hospital
Published: 2026-01-01

Written by

Mustafa Çelik Liv Hospital Content Team

Medically reviewed by

Kidney Cancer Treatment Cost: India, Surat vs Turkey

Introduction & Clinical Importance

Kidney cancer treatment targets renal cell carcinoma, the most common type, using surgery like partial or radical nephrectomy, targeted therapies, immunotherapy, or ablation for early stages. Applied when tumors are detected via imaging, it improves survival rates but may impact kidney function, causing fatigue or hypertension, affecting quality of life.

In India, particularly Surat, high demand in public facilities leads to long waiting times and limited private access without insurance. Turkey excels in medical tourism with JCI-accredited centers treating thousands of international patients yearly.

Price Comparison: India, Surat vs Turkey

Average costs in India (including Surat private centers): $3,500–$7,500 USD for surgery packages, covering consultation, tests, procedure, 3-day stay, and meds. Public options lower but with waits.

In Turkey: $6,500–$15,000 USD (approx. €4,000–€15,000), including similar all-inclusive elements plus tourism support.

Turkey offers competitive value; patients often find balanced pricing with superior services.

Turkey’s Price Advantage and Superiorities

Driven by favorable exchange rates, efficient operations, and tourism competition.
Short flights, e-visas, English/Arabic/Russian support, and packages with transfers/hotels enhance experience.
High case volumes build expertise in kidney cancer care.

Treatment Options, Modalities, and Medical Technologies

Main options: robotic/ laparoscopic nephrectomy, targeted drugs (e.g., sunitinib), immunotherapy. Risks include bleeding, infection (5-10% rate).

Turkey’s JCI centers use robotic systems, advanced imaging meeting global standards. India, Surat offers similar tech but more limited access in some facilities.